Sarcoidosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Condition:   Pulmonary Sarcoidosis Interventions:   Drug: Efzofitimod 3 mg/kg;   Drug: Efzofitimod 5 mg/kg;   Drug: Placebo Sponsors:   aTyr Pharma, Inc.;   Kyorin Pharmaceutical Co.,Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials